Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions

Journal of the American Pharmacists Association

Volumn 54, Issue 3, 2014, Pages 241-250

  Fleming, Marc L ^a   Barner, Jamie C ^b   Brown, Carolyn M ^b   Shepherd, Marv D ^b   Strassels, Scott A ^b   Novak, Suzanne ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Diversion; Opioid addiction; Pharmacists; Prescription drug abuse; Prescription drug monitoring

Indexed keywords

CONTROLLED SUBSTANCE; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; ANALGESIA; ARTICLE; CONTINUING EDUCATION; CONTINUING PHARMACY EDUCATION; CONTROLLED SUBSTANCE PRESCRIPTION; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; LAW ENFORCEMENT; MALE; OPIATE ADDICTION; PHARMACIST ATTITUDE; PHYSICIAN; PRESCRIPTION; PRESCRIPTION DRUG DIVERSION; PRESCRIPTION DRUG MONITORING PROGRAM; CROSS-SECTIONAL STUDY; DRUG MONITORING; EDUCATION; HEALTH PERSONNEL ATTITUDE; INFORMATION PROCESSING; MIDDLE AGED; PHARMACIST; PHARMACY; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; CONTROLLED SUBSTANCES; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG MONITORING; DRUG PRESCRIPTIONS; EDUCATION, PHARMACY, CONTINUING; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACIES; PHARMACISTS; PRESCRIPTION DRUGS; SUBSTANCE-RELATED DISORDERS; TEXAS;

EID: 84901402608     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2014.13168     Document Type: Article

References (41)

1. Paulozzi LJ, Jones CM, Mack KA, et al. Vital signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487-1492.
2. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: High-lights of the 2010 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. www.samhsa.gov/data/2k12/DAWN096/SR096EDHighlights2010.htm. Accessed August 4, 2012.
3. Blumenschein K, Fink JL III, Freeman PR, et al. Review of prescription drug monitoring programs in the United States. http://chfs.ky.gov/NR/rdonlyres/ 85989824-1030-4AA6-91E1-7F9E3EF68827/0/ KASPEREvaluationPDMPStatusFinalReport6242010.pdf. Accessed May 3, 2011.
4. Drug Enforcement Administration, Office of Diversion Control. State Prescription Drug Monitoring Programs: Questions and Answers - What is the difference between HRPDMP and NASPER? www.deadiversion.usdoj.gov/faq/rx-monitor. htm#10. Accessed September 29, 2011.
5. National Allicance for Model State Drug Laws. Prescription drug monitoring programs (Administration of PDMPs); Executive summary - prescription drug abuse, addiction and diversion: Overview of State Legislative and Policy Initiatives, Part 1 (March 2014). www.namsdl.org/prescription-monitoring- programs.cfm. Accessed May 1, 2014.
6. U.S. Government Accountability Office. Prescription drugs: state monitoring programs provide useful tool to reduce diversion. http://www. gao.gov/products/GAO-02-634. Accessed April 25, 2010.
7. Griggs CA, Weiner SG. 271 prescription monitoring programs: current use and impressions. Ann Emerg Med. 2011;58(4):S268.
8. Brushwood DB. From confrontation to collaboration: collegial accountability and the expanding role of pharmacists in the management of chronic pain. J Law Med Ethics. 2001;29(1):69-93. (Pubitemid 33804227)
9. Joranson DE, Gilson AM. Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. J Am Pharm Assoc. 2001;41(2):213-220.
10. Koski RR. Pharmacists' perceptions of controlled substance abuse in the rural upper peninsula of Michigan. J Am Pharm Assoc. 2006;46(6):751-753. (Pubitemid 46037336)
11. Texas Department of Public Safety. DPS launches online version of Texas prescription drug monitoring program. www.dps.texas.gov/director-staff/public- information/pr080212.htm. Accessed August 3, 2012.
12. Drug Enforcement Administration, Office of Diversion Control. Pharmacist's manual: an informational outline of the Controlled Substances Act. 2010 ed. www.deadiversion.usdoj.gov/pubs/manuals/pharm2/pharm-manual.pdf. Accessed October 19, 2010.
13. National Center on Addiction and Substance Abuse at Columbia University. Under the counter: the diversion and abuse of controlled prescription drugs in the U.S. www.casacolumbia.org/addiction-research/reports/under-the-counter- diversion-abuse-controlled-perscription-drugs. Accessed April 29, 2009.
14. Blumenschein K. Prescription drug diversion: fraudulent tactics utilized in the community pharmacy. Am J Pharm Educ. 1997;61(2):184-188.
15. Green TC, Mann MR, Bowman SE, et al. How does use of a prescription monitoring program change pharmacy practice? J Am Pharm Assoc. 2013;53(3):273-281.
16. Furstenberg CT, Ahles TA, Whedon MB, et al. Knowledge and attitudes of health-care providers toward cancer pain management: a comparison of physicians, nurses, and pharmacists in the state of New Hampshire. J Pain Symptom Manage. 1998;15(6):335-349. (Pubitemid 28328432)
17. Lafferty L, Hunter TS, Marsh WA. Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse. J Psychoactive Drugs. 2006;38(3):229-232. (Pubitemid 44759959)
18. Green CR, Ndao-Brumblay SK, West B, et al. Differences in prescription opioid analgesic availability: comparing minority and white pharmacies across Michigan. J Pain. 2005;6(10):689-699. (Pubitemid 41395061)
19. Greenwald BD, Narcessian EJ. Opioids for managing patients with chronic pain: community pharmacists' perspectives and concerns. J Pain Symptom Manage. 1999;17(5):369-375. (Pubitemid 29239529)
20. Kanner RM, Portenoy RK. Unavailability of narcotic analgesics for ambulatory cancer patients in New York City. J Pain Symptom Manage. 1986;1(2):87-89. (Pubitemid 16005966)
21. Morrison RS, Wallenstein S, Natale DK, et al. "We don't carry that" - failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med. 2000;342(14):1023-1026. (Pubitemid 30180650)
22. Ponte CD, Johnson-Tribino J. Attitudes and knowledge about pain among West Virginia pharmacists. J Am Pharm Assoc. 2007;47(3):379-382.
23. Fleming ML, Barner JC, Brown CM, et al. Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database. Res Social Adm Pharm. 2014;10(2):285-296.
24. Gavaza P, Fleming M, Barner JC. Examination of psychosocial predictors of Virginia pharmacists' intention to utilize a prescription drug monitoring program using the theory of planned behavior. Res Social Adm Pharm. 2014;10(2):448-458.
25. Perrone J, DeRoos FJ, Nelson LS. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012. J Med Toxicol. 2012;8(4):341-352.
26. Ulbrich TR, Dula CA, Green CG, et al. Factors influencing community pharmacists' enrollment in a state prescription monitoring program. J Am Pharm Assoc. 2010;50(5):588-594.
27. Blumenschein K, Fink JL, Freeman PR, Kirsh KL, Steinke DT, Talbert JC. Independent Evaluation of the Impact and Effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER). 2010. http://chfs.ky.gov/NR/rdonlyres/24493B2E-B1A1-4399-89AD-1625953BAD43/0/ KASPEREvaluationFinalReport10152010.pdf. Accessed November 10, 2010.
28. Sorg M, LaBrie S, Parker W. Analysis and evaluation of participation by prescribers and dispensers in the Maine state prescription monitoring program. 2009. http://mcspolicycenter.umaine.edu/files/pdf/PMP%20Report%20Final%20Nov09. pdf. Accessed July 24, 2012.
29. Fleming ML, Chandwani H, Barner JC, Weber SN, Okoro TT. Prescribers and pharmacists requests for prescription monitoring program (PMP) data: does PMP structure matter? J Pain Palliat Care Pharmacother. 2013;27(2):136-142.
30. Virginia Department of Health Professions. Virginia Prescription Monitoring Program: 2012 program statistics. www.dhp.virginia.gov/dhp-programs/ pmp/pmp-reports.asp. Accessed October 13, 2013.
31. Virginia Department of Health Professions. Third Quarter 2013 Program Statistics. 2014. www.dhp.virginia.gov/dhp-programs/pmp/pmp-reports.asp. Accessed May 1, 2014.
32. Tommasello AC. Substance abuse and pharmacy practice: what the community pharmacist needs to know about drug abuse and dependence. Harm Reduction Journal. 2004;1(3):263-271.
33. Wallace J. The pharmacist's role in managing chronic opioid therapy. Curr Pain Headache Rep. 2006;10(4):245-252. (Pubitemid 44122746)
34. Brushwood DB. From confrontation to collaboration: collegial accountability and the expanding role of pharmacists in the management of chronic pain. J Law Med Ethics. 2001;29(1):69-93. (Pubitemid 33804227)
35. Gasbarro R. Does the Rx look suspicious? Pharmacists need to strike a careful balance when handling questionable prescriptions for drugs with abuse potential. Am Drug. 1999;216(1):48(44).
36. Texas Department of Public Safety. Texas Prescription Program: Overview. www.txdps.state.tx.us/RegulatoryServices/prescription-program. Accessed December 6, 2013.
37. Dillman DA, Smyth JD, Christian LM. Internet, mail, and mixed-mode surveys: the tailored design method. 3rd ed. Hoboken, NJ: John Wiley and Sons, Inc; 2009.
38. Gavaza P, Brown CM, Lawson KA, et al. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Social Adm Pharm. 2011;7(4):369-382.
39. Griggs SK, Brown CM. Texas community pharmacists' willingness to participate in pharmacist-initiated emergency contraception. J Am Pharm Assoc. 2007;47(1):48-57.
40. Wenthur CJ, Cross BS, Vernon VP, et al. Opinions and experiences of Indiana pharmacists and student pharmacists: the need for addiction and substance abuse education in the United States. Res Social Adm Pharm. 2013;9(1):90-100.
41. Texas Department of Public Safety. Texas Prescription Program: The Prescription Forms. 2011. www.txdps.state.tx.us/RegulatoryServices/prescription- program/prescriptionforms.htm. Accessed June 10, 2011.